Differential cardiovascular profiles of sodium-glucose cotransporter 2 inhibitors: critical evaluation of empagliflozin

Sanon VP, Patel S, Sanon S, Rodriguez R, Pham SV, Chilton R

Therapeutics and Clinical Risk Management 2017, 13:603-611

Published Date: 3 May 2017